Adial Pharmaceuticals, Inc. (ADIL)
0.242
+0.01
(+3.64%)
USD |
NASDAQ |
Jan 09, 16:00
0.2426
0.00 (0.00%)
After-Hours: 20:00
Adial Pharmaceuticals EPS Diluted (Quarterly): -0.0809 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Acurx Pharmaceuticals, Inc. | -1.226 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.794M |
| Total Expenses (Quarterly) | 1.794M |
| Enterprise Value | 1.199M |
| Earnings Yield | -382.6% |
| Normalized Earnings Yield | -382.60 |